Aggir Ventures

Aggir Ventures is a Brazilian venture capital firm specializing in early-stage investments within the digital health sector. The firm aims to enhance the Brazilian healthcare landscape by supporting innovative startups that are poised to transform the industry. By leveraging a collaborative network of experts, Aggir Ventures seeks to invest in technology-driven companies and share knowledge and trends within the sector.

Established on October 26, 2020, in Rio de Janeiro, Aggir Ventures has been actively involved in the Brazilian healthtech ecosystem. The firm's investment strategy focuses on sectors such as hospital management, clinical management, corporate health, mental health, chronic diseases, telemedicine, senior care, women's health, oncology, and ophthalmology. Notably, Aggir Ventures launched the Aggir Ventures Health fund, a R$ 100 million venture capital fund with a 10-year term, aiming to build a portfolio of up to 15 startups in Seed and Series A stages. The first institutional investor in this fund was SulAmérica, a prominent health insurance company in Brazil.

Aggir Ventures' approach emphasizes a hands-on, participatory model, providing portfolio companies with access to a vast network of industry professionals. This network includes doctors, healthcare executives, and entrepreneurs who serve as limited partners, offering strategic guidance and potential business opportunities. The firm's commitment to fostering innovation in the healthcare sector is evident through its active participation in initiatives like the Agro 4.0 program, which supports agtech startups in Brazil. By aligning with such programs, Aggir Ventures demonstrates its dedication to advancing technological solutions that address critical challenges in the healthcare industry.

Aggir Ventures' portfolio includes investments in companies like Deepful, a pharmaceutical-specific AI-powered role-playing platform aimed at improving commercial performance. The firm's strategic focus on digital health and its collaborative investment approach position it as a significant player in Brazil's venture capital landscape, dedicated to driving positive change in the healthcare sector.